Beizray Injection, Solution
Product Images NDC 70710-2152

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Beizray (NDC 70710-2152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 01)

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 02)

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 03)

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 04)

This text appears to show a graph or chart related to cumulative probability, overall survival, and survival time in months. The logrank p-value is noted as 0.010. The graph seems to display data points corresponding to different months and their respective probabilities.*

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 05)

This is a description of a chart showing cumulative probability of overall survival over different time intervals in months. The logrank p-value is shown as 0.013, indicating statistical significance. The chart also includes numeric values ranging from 00 to 10.*

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 06)

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 07)

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 08)

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 09)

Progression Free Survival Probability (%): 2% Progression Free Survival Time (months)*

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 10)

FDA Label Image

Image (8af4a374 Dc96 4931 943e C7b5e3ad1044 11)

FDA Label Image

Vial (8af4a374 Dc96 4931 943e C7b5e3ad1044 12)

FDA Label Image

80 mg Kit (8af4a374 Dc96 4931 943e C7b5e3ad1044 13)

BEIZRAY™ is a docetaxel injection used for intravenous infusion only. Each vial contains 80 mg/4 mL of the medication and must be diluted in a solution containing Albumin Human USP and 0.8% Sodium Chloride Injection. It is important not to substitute BEIZRAY with other docetaxel products. The drug is labeled as a hazardous substance and comes with specific instructions for handling and disposal. The product details are available in a standardized format including LOT number, expiration date, and additional identification codes for safety and traceability purposes.*

FDA Label Image

160 mg Kit (8af4a374 Dc96 4931 943e C7b5e3ad1044 14)

This is a description for BEIZRAY™ (docetaxel) injection in vials of 80 mg/4 mL for intravenous infusion only. The product contains a solution with human albumin USP. The label warns that BEIZRAY should not be substituted with other products, and emphasizes that it is hazardous. The dimensions of the vial are approximately 53mm x 105mm. The label includes a lot number and other applicable information related to the product.*

FDA Label Image

80 mg Carton (8af4a374 Dc96 4931 943e C7b5e3ad1044 15)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.